Search
Searching Content from Canada indexed under Life Sciences, Biotechnology & Nanotechnology ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
The USMCA And Its Impact On Agriculture
The United States-Mexico-Canada Agreement (USMCA) is antipcipated to replace the North America Free Trade Agreement (NAFTA) on January 1, 2020.
Canada
21 Oct 2019
2
Drug Price Cooling In Canada's Election Year: Release Of Final PMPRB Regulations
Final amendments to the Patented Medicines Regulations have been announced by the Government of Canada giving the Patented Medicine Prices Review Board
Canada
16 Aug 2019
3
New Mandatory Regulations Require Hospitals To Report Serious Adverse Drug Reactions And Medical Device Incidents
Drugs and medical devices are integral parts of the Canadian health care system, used by many to treat and prevent a variety of conditions.
Canada
9 Aug 2019
4
Regulations Will Require Hospitals To Report Serious Adverse Drug Reactions And Medical Device Incidents
On June 10, 2019, the Regulations Amending the Food and Drug Regulations (Serious Adverse Drug Reaction Reporting – Hospitals)and Regulations Amending the Medical Devices Regulations
Canada
5 Aug 2019
5
Biosimilars No Longer Reviewed By CADTH
The Canadian Agency for Drugs and Technologies in Health (CADTH) released Issue 8 of its Pharmaceutical Reviews Update announcing updates
Canada
5 Aug 2019
6
Health Canada, TPD And BGTD Annual Reports Released
On June 27, 2019, Health Canada published Drug and medical device highlights 2018: Helping you maintain and improve your health, an annual highlights report for 2018.
Canada
5 Aug 2019
7
Competition Bureau Issues Statement Regarding Off-Label Use Of Vaccines
The Competition Bureau recently conducted a preliminary investigation into possible competition concerns arising from a proposal to include a clause in a procurement contract that would restrict off-label use of a vaccine.
Canada
31 Jul 2019
8
Le nouveau document d'orientation de Santé Canada sur les activités d'ordre promotionnel et non promotionnel est enfin disponible!
Le présent bulletin est destiné aux fabricants de produits pharmaceutiques et d'instruments médicaux et à ceux qui en font la promotion.
Canada
25 Jul 2019
9
Federal Court Of Appeal's Ruling On The Judicial Review Of PMPRB Decision On Differin
On June 28, the Federal Court of Appeal (FCA) affirmed the lower court's approach to patent review in determining whether the Patented Medicine Prices Review Board (PMPRB)
Canada
22 Jul 2019
10
Après un second coup d'œil, la CAF confirme le rejet de demande en contrefaçon dans un litige portant sur des dispositifs médicaux ophtalmiques
Dans TearLab Corporation c. I-MED Pharma Inc, 2019 FCA 179, la Cour d'Appel Fédérale (CAF) a confirmé le rejet de l'action en contrefaçon de brevet de TearLab contre I-MED.
Canada
19 Jul 2019
11
Biosimilars: Market Access, Naming, Studying Usage
As of June 30, Health Canada had approved 16 biosimilars, based on 11 comparator products (3 in 2019).
Canada
16 Jul 2019
12
Health Canada: Statutory And Regulatory Amendments, Medical Devices Updates, Court Decisions, Revised CSP Guidance
Food and Drugs Act amendments: Bill C-97, tabled in April, proposed amendments to the Food and Drugs Act, including a new framework for "Advanced Therapeutic Products"
Canada
16 Jul 2019
13
Canada
16 Jul 2019
14
New Mandatory Reporting Requirements For Hospitals
On June 26, 2019, the federal government, under the authorities granted by the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law), adopted new mandatory reporting requirements for hospitals across the country.
Canada
16 Jul 2019
15
Federal Court Of Appeal Agrees That The PMPRB Incorrectly Applied The Patent-Pertaining Analysis
The Federal Court of Appeal has provided new guidance on the proper approach to the "patent pertaining" analysis used by the Patented Medicine Prices Review Board, including on the identification of the medicine ...
Canada
11 Jul 2019
16
All Eyes On Hospitals: Mandatory Drug And Medical Device Adverse Event Reporting
Traditionally, Health Canada has only required drug and medical device manufacturers to report serious adverse drug reactions and adverse events involving these products
Canada
10 Jul 2019
17
Medical Devices Update
On June 15, 2019, the Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Post-market Surveillance of Medical Devices) (Regulations) were pre-published
Canada
10 Jul 2019
18
Operationalizing Health Canada's Authority To Assess Medical Devices Post-Approval: The Latest On The Regulatory Consultation Process
In 2014, amendments to the Food and Drugs Act gave the federal Minister of Health authority with respect to the safety of drugs, medical devices and other therapeutic devices that are already
Canada
9 Jul 2019
19
PMPRB Decision Stands: Soliris Priced Excessively
The Federal Court has dismissed an application for judicial review by Alexion Pharmaceuticals Inc. (Alexion) in relation to a decision of the Patented Medicine Prices
Canada
8 Jul 2019
20
Revised Canadian Intellectual Property Enforcement Guidelines: Worth A Closer Look
On March 13, 2019, the Canadian Competition Bureau issued revised Intellectual Property Enforcement Guidelines (the IPEGs).
Canada
8 Jul 2019
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next